Case studies

Biomarkers are proposed to replace surrogate endpoints in clinical preliminaries process. Surrogate markers are utilized to direct the clinical trial and assemble a few endpoints which is illogical when the essential endpoint is undesired, or the occasion number is little. Biomarkers help in the diagnostics and clinical advancement forms. Biomarkers contextual analysis assumes a vital part in finding new medications for the patients who require new medications and to be utilized broadly in different clinical practices.
 
  • MicroRNA’s
  • CTCs
  • Circulating free DNA
  • Exosomes
  • Biomarker to Diagnostic